Posted on August 25th, 20208/25/20
Country: PAKISTAN | Region: ASIA & SOUTH PACIFIC | Type: Price Changes | Keywords: #covid19 #drap #drugpricingpolicy #drugshortages #essentialmedicines #nationalhealthservice #priceincreases PRICENTRIC BRIEF: The Ministry of National Health Services Regulation and Coordination (NHSR&C) allowed pharmaceutical companies to increase the prices of essential drugs by 7% and non-essential drugs by 10%, in accordance with the annual consumer price index (CPI) However, pharmaceutical companies decided against […]
Posted on August 19th, 20208/19/20
Country: CHINA | Region: ASIA & SOUTH PACIFIC | Type: Policy | Keywords: #basicmedicalinsurance #bidding #negotiations #nhsa #nmpa #nrdl #pricingandreimbursement PRICENTRIC BRIEF: The National Healthcare Security Administration (NHSA) of China has issued its official work plan for revisions to the 2020 National Reimbursed Drug List (NRDL), including application guidelines for revision of the list Some criteria for inclusion in the 2020 NRDL include: the drug must intend to treat […]
Posted on August 19th, 20208/19/20
Country: NETHERLANDS | Region: EUROPE | Type: Reference Pricing (IRP) | Keywords: #covid19 #drugshortages #drugsupply #generics #hospitalmedicines #maximumprices #medicinespricingact #ministryofhealthwelfareandsport #policy #referencebasket #wgp PRICENTRIC BRIEF: The Netherlands will be implementing its new international reference pricing (IRP) rule from October 1, 2020; originally, the rule was supposed to take effect April 1 of this year Via the Medicines Pricing Act (WGP), maximum prices are […]
Posted on July 21st, 20207/21/20
Region: ASIA & SOUTH PACIFIC | Type: Policy | Keywords: #annualpricehikes #drap #drugpricingpolicy #nationalhealthservice #priceincreases PRICENTRIC BRIEF: The Drug Pricing Policy, 2018 has been revised by the federal government to allow the government to prevent pharmaceutical companies from annual price increases for a category of drugs, announced the Ministry of National Health Services Previously under the Drug Pricing Policy, 2018, pharmaceutical companies were granted […]
Posted on July 14th, 20207/14/20
Country: PANAMA | Region: SOUTH AMERICA | Type: Regulation | Keywords: #855 #agencies #covid-19 #drugstores #executivedecree #import #laboratories PRICENTRIC BRIEF: Under Executive Decree No. 855, agencies, drugstores and laboratories with a valid license in Panama, granted by the National Directorate of Pharmacy and Drugs, will be allowed to import drugs for the treatment of COVID-19 Under Article 3 of the Decree, the responsibility of importing drugs for the treatment of […]
Posted on July 8th, 20207/8/20
Region: EUROPE | Type: Policy | Keywords: #biosimilars #capf #drugevaluation #generics #hta #innovation #irp #newindications #pricesetting #referencepricing #therapeuticpositioningreports PRICENTRIC BRIEF: The Advisory Committee for the Financing of Pharmaceutical Provisions (CAPF) under the National Health Service (SNS) has put forth a series of proposals to address, in the medium term, the pricing and financing strategies of medicines in Spain The below plan for CAPF will be addressed over the next two years […]
Posted on June 30th, 20206/30/20
Country: SOUTH KOREA | Region: ASIA & SOUTH PACIFIC | Type: Policy | Keywords: #domesticproduction #drugsupply #genericdruguse #generics #krpia #nhis #oecd #pricecuts #regulation PRICENTRIC BRIEF: Head researcher Professor Lee Sang-won of the National Health Insurance Service (NHIS)-commissioned project, “Improvement of Drug Supply and Purchasing System,” has expressed support for South Korean health policy to lower generic drug prices and expand their use Generics in OECD countries comprise 70% of total […]
Posted on May 13th, 20205/13/20
Country: UNITED STATES | Region: NORTH AMERICA | Type: Regulation | Keywords: #minnesota #priceincrease #proposal PRICENTRIC BRIEF: Aiming to cut down on price hikes, the Minnesota House of Representatives approved a proposal ordering drug manufacturers to justify large increases in prescription drug costs, and Gov. Tim Walz is expected to sign the measure into law The bill would require drug manufacturers that priced prescriptions drugs at […]
Posted on January 27th, 20201/27/20
Country: IRELAND | Region: EUROPE | Type: Policy | Keywords: #hse #ipha #newmedicinespolicy #patientaccess #pricingandreimbursement #sustainability PRICENTRIC BRIEF: The Irish Pharmaceutical Healthcare Association (IPHA), the representative body of the international originator biopharmaceutical industry in Ireland, has urged all political parties to pledge to improve patients’ access to new medicines as part of their plans for health during general elections Ireland is among the slowest in Western Europe to provide […]
Posted on December 30th, 201912/30/19
Country: NETHERLANDS | Region: EUROPE | Type: Reference Pricing (IRP) | Keywords: #maximumdrugprices #medicinespricesact #ministryofmedicalcare #patentedmedicines #policy #regulation PRICENTRIC BRIEF: Since 1996, a maximum price for medicines in the Netherlands has been based on the average price in Germany, Belgium, France, and the United Kingdom; however, the Netherlands is swapping out Germany for Norway, where prices tend to be lower Bruno Bruins, Minister of Medical Care, said, […]
